• World News
  • Investing
  • Tech News
  • Stock
  • Editor’s Pick
ResearchOfMarkets.com

Jeffrey A. Singer

Yesterday the House of Representatives voted 289–133 to pass the HALT Fentanyl Act.* The act permanently classifies fentanyl‐​related substances (FRS)—analogs of fentanyl that differ chemically from analogs currently used medically (e.g., sufentanil, remilfentanil, alfentanil)—as Schedule 1 drugs. The Drug Enforcement Administration defines Schedule 1 drugs as having “no currently accepted medical use and a high potential for abuse.”

Set aside the fact that politicians have no way of knowing that future analogs have no potential medical use (think of all those years lost in treating mental health problems with psychedelics because the DEA determined they had no accepted medical use). Set aside the fact that keeping heroin and cannabis as Schedule 1 drugs for more than half a century has not deterred the black market from providing those drugs to consumers. What is even more mind‐​boggling is that the Trump Administration temporarily classified FRSs Schedule 1 in 2018 as an emergency measure in response to the rise in fentanyl‐​related overdose deaths, and renewed the temporary classification in 2020 through 2024. Fentanyl‐​related overdose deaths went from roughly 47,000 in 2018 to more than 81,000 in 2022. By what logic do lawmakers think that permanently extending FRSs Schedule 1 classification will somehow bring overdose deaths down?

The HALT Fentanyl Act also increases mandatory minimum sentences for people found possessing fentanyl‐​related substances. Experience shows that mandatory minimum sentences and even the death penalty do nothing to deter drug dealing and drug use. Mandatory minimums do, however, empower prosecutors to engage in coercive plea bargaining.

In testimony before the House Judiciary Committee Subcommittee on Crime and Government Surveillance last March I urged lawmakers not to go down this road.

The bill now goes to the Senate, and President Biden signals he will sign it.

The HALT Fentanyl Act is just the latest example of Congress doing the same thing over and over and expecting a different result. This is prohibition denialism.

*HALT Fentanyl Act is an acronym for “Halt All Lethal Trafficking of Fentanyl Act”

0 comment
0
FacebookTwitterPinterestEmail

previous post
Representative Mooney Calls Out Fed’s CBDC Pilots
next post
Friday Feature: Challenger School

You may also like

Docusign Stock: Does It Look Promising, or Still...

June 1, 2023

Four MACD Patterns That Repeat

June 1, 2023

Glacier Northwest v. Teamsters: The Supreme Court Gets...

June 1, 2023

Nearly a Third of Gen Z Favors the Government Installing...

June 1, 2023

Krugman Misses the Mark on CBDCs—Again

June 1, 2023

Brookings Paper Is Not Concrete Evidence That a...

June 1, 2023

Misleading Debt Limit Deal Math Counts Phantom Savings

June 1, 2023

Scanning for Strong Reversals via Bullish Engulfing Patterns

May 31, 2023

Consumer Sector ETF XRT Has Some Words for...

May 31, 2023

The Ord Oracle May 30, 2023

May 31, 2023

    Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recent Posts

    • Docusign Stock: Does It Look Promising, or Still Iffy?

      June 1, 2023
    • The Fed Is Insolvent, and That’s a Bad Thing

      June 1, 2023
    • Four MACD Patterns That Repeat

      June 1, 2023
    • Quest 3 won’t replace Quest 2 for ‘quite a while,’ confirms Meta

      June 1, 2023
    • Glacier Northwest v. Teamsters: The Supreme Court Gets Concrete

      June 1, 2023
    • About Us
    • Contacts
    • Email Whitelisting
    • Privacy Policy
    • Terms and Conditions

    Copyright © 2023 ResearchOfMarkets.com All Rights Reserved.

    ResearchOfMarkets.com
    • World News
    • Investing
    • Tech News
    • Stock
    • Editor’s Pick